Currently, formal guidelines for the diagnosis and management of MCT8 deficiency do not exist, with diagnosis based on clinical signs and symptoms with a characteristic pattern of thyroid hormone levels in the blood, and confirmatory genetic testing (1). The gene discussed is SLC16A2; the disease is hyperinsulinemic hypoglycemia, familial, 4.